Increased tissue iron in patients with pernicious anemia was first described in 1910, by Ryffel,1 who used autopsy material. Increased hemosiderin in bone marrow aspirates was demonstrated in 1948, by Rath and Finch,2 who showed that such a rise in bone marrow hemosiderin is common to all anemias except that of iron deficiency and that it is due largely to a shift of iron from the red blood cells to storage.3 Beutler recently reviewed quantitative aspects of iron stores.4 The present study of marrow hemosiderin deals with its pattern of distribution rather than its total amount. Whenever possible observations on its microscopic appearance were correlated with data obtained from ferrokinetic measurements.
Methods and Material
Bone marrow aspirations were performed using a 16 gauge needle* and a 10 ml. syringe previously rinsed with a 10% solution of edathamil disodium (Disodium Versenate). The aspirate was ejected on an
WALLERSTEIN RO, COVE MP. Bone Marrow Hemosiderin and Ferrokinetics Patterns in Anemia: I. Pernicious Anemia. AMA Arch Intern Med. 1958;101(2):418–424. doi:10.1001/archinte.1958.00260140250035
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: